Cargando…

Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung

BACKGROUND: Adenocarcinoma of the lung is a type of non-small cell lung cancer (NSCLC). Clinical outcome is associated with tumor grade, stage, and subtype. This study aimed to identify RNA expression profiles, including long noncoding RNA (lncRNA), microRNA (miRNA), and mRNA, associated with clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Si-Yu, Xi, Wen-Jing, Wang, Xin, Xu, Chao-Han, Cheng, Liang, Liu, Si-Yao, Meng, Qian-Qian, Li, Boyan, Wang, Yahui, Shi, Hong-Bo, Wang, Hong-Jiu, Wang, Zhen-Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2019
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556069/ https://www.ncbi.nlm.nih.gov/pubmed/31132294 http://dx.doi.org/10.12659/MSM.913727

Ejemplares similares

5-mRNA-based prognostic signature of survival in lung adenocarcinoma
por: Xia, Qian-Lin, et al.
Publicado: (2023)

Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

Identification of Prognostic DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Pengli, et al.
Publicado: (2022)

Identification of a novel prognostic DNA methylation signature for lung adenocarcinoma based on consensus clustering method
por: Cai, Qidong, et al.
Publicado: (2020)

Identification of an eight-gene prognostic signature for lung adenocarcinoma
por: Li, Shicheng, et al.
Publicado: (2018)

Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma
por: Miao, Yan-Dong, et al.
Publicado: (2021)

Identification of Extracellular Matrix Signatures as Novel Potential Prognostic Biomarkers in Lung Adenocarcinoma
por: Zeng, Zhen, et al.
Publicado: (2022)

Identification of a prognostic ferroptosis-related lncRNA signature in the tumor microenvironment of lung adenocarcinoma
por: Guo, Yugang, et al.
Publicado: (2021)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021)

Identification of four differentially methylated genes as prognostic signatures for stage I lung adenocarcinoma
por: Luo, Wei-Ming, et al.
Publicado: (2018)

Identification and Validation of a GPX4-Related Immune Prognostic Signature for Lung Adenocarcinoma
por: Feng, Zhenxing, et al.
Publicado: (2022)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Identification of an Exosome-Related Signature for Predicting Prognosis, Immunotherapy Efficacy, and Tumor Microenvironment in Lung Adenocarcinoma
por: Lin, Tao, et al.
Publicado: (2022)

Development and validation of a combined ferroptosis and immune prognostic signature for lung adenocarcinoma
por: Li, Han, et al.
Publicado: (2022)

Identification of Aberrant Chromosomal Regions in Human Breast Cancer Using Gene Expression Data and Related Gene Information
por: Wang, Hong-Jiu, et al.
Publicado: (2015)

Prognostic and predictive value of radiomic signature in stage I lung adenocarcinomas following complete lobectomy
por: Nie, Wei, et al.
Publicado: (2022)

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
por: Zhang, Wentao, et al.
Publicado: (2023)

P190(BCR-ABL) Chronic Myeloid Leukemia Following a Course of S-1 Plus Oxaliplatin Therapy for Advanced Gastric Adenocarcinoma
por: Wang, Hua, et al.
Publicado: (2017)

Identification and External Validation of a Transcription Factor-Related Prognostic Signature in Pediatric Neuroblastoma
por: Wang, Rujia, et al.
Publicado: (2021)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Identification of fatty acid-related subtypes, the establishment of a prognostic signature, and immune infiltration characteristics in lung adenocarcinoma
por: Wang, Yuzhi, et al.
Publicado: (2023)

Identification and experimental verification of an anoikis and immune related signature in prognosis for lung adenocarcinoma
por: Zhang, Jia-Le, et al.
Publicado: (2023)

Identification of Bone Metastatic and Prognostic Alternative Splicing Signatures in Prostate Adenocarcinoma
por: Zhu, Jiwen, et al.
Publicado: (2023)

Identification and Validation of a Novel Necroptosis-Related Long Noncoding RNA Prognostic Signature for Lung Adenocarcinoma
por: Zeng, Cheng, et al.
Publicado: (2022)

Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism‐related genes
por: Wang, Zhihao, et al.
Publicado: (2021)

The prognostic value of oxidative stress and inflammation in Chinese hemodialysis patients
por: Wang, Zhen, et al.
Publicado: (2016)

Identification of Prognostic Markers and Potential Therapeutic Targets in Gastric Adenocarcinoma by Machine Learning Based on mRNAsi Index
por: Guo, Si Hong, et al.
Publicado: (2022)

Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation
por: Chen, Si-Si, et al.
Publicado: (2021)

Identification and Validation a Necroptosis‑related Prognostic Signature and Associated Regulatory Axis in Stomach Adenocarcinoma
por: Wang, Ning, et al.
Publicado: (2021)

Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma
por: Yue, Cheng, et al.
Publicado: (2019)

Identification of a multidimensional transcriptome prognostic signature for lung adenocarcinoma
por: Ye, Jing, et al.
Publicado: (2019)

Identification of an immune prognostic 11-gene signature for lung adenocarcinoma
por: Yang, Tao, et al.
Publicado: (2021)

Identification of an Immune Classification and Prognostic Genes for Lung Adenocarcinoma Based on Immune Cell Signatures
por: Deng, Lili, et al.
Publicado: (2022)

Prognostic Significance of Gene Signature of Tertiary Lymphoid Structures in Patients With Lung Adenocarcinoma
por: Feng, Hong, et al.
Publicado: (2021)

Autophagy-related long non-coding RNA prognostic model predicts prognosis and survival of melanoma patients
por: Qiu, Yue, et al.
Publicado: (2022)

Clinicopathological characteristics and prognostic factors of cervical adenocarcinoma
por: Wang, Min, et al.
Publicado: (2021)

Identification of a Novel Cuproptosis-Related Gene Signature for Prognostic Implication in Head and Neck Squamous Carcinomas
por: Tang, Shouyi, et al.
Publicado: (2022)

A novel prognostic signature of metastasis-associated genes and personalized therapeutic strategy for lung adenocarcinoma patients
por: Wang, Zhihao, et al.
Publicado: (2022)

The value of a metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction
por: Tan, Zhen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6d01p0bho0766c1g2mb6uivi9h